Compositions and methods utilizing DNA polymerases
View Patent ↗The invention features a novel isolated Family B DNA polymerase, a Thermococcus polymerase JDF-3, and mutant recombinant forms thereof. Mutant polymerases of the invention are deficient in 3′ to 5′ exonuclease activity and/or exhibit reduced discrimination against non-conventional nucleotides relative to the wild-type form of the polymerase.
1. A purified thermostable DNA polymerase having an amino acid sequence presented in SEQ ID NO: 2 from residue 1 to 776.
2. An isolated recombinant polypeptide comprising the amino acid sequence of SEQ ID NO: 2.
3. An isolated recombinant JDF-3 DNA polymerase comprising a sequence of SEQ ID NO: 2 and further comprising a mutation at D141 and/or E143 within said sequence of SEQ ID NO: 2.
4. The isolated recombinant JDF-3 DNA polymerase of claim 3 , wherein said mutation at D141 is an aspartic acid (D) to threonine (T) or alanine (A) mutation, and said mutation at E143 is a glutamic acid (E) to alanine (A) mutation.
5. The isolated recombinant JDF-3 DNA polymerase of claim 3 or 4 , further comprising a mutation at L408 and/or P410.
6. The isolated recombinant JDF-3 DNA polymerase of claim 5 , wherein said mutation at L408 is a leucine (L) to histidine (H) or phenylalanine (F) mutation and said mutation at P410 is a proline (P) to leucine (L) mutation.
7. The isolated recombinant JDF-3 DNA polymerase of claim 3 or 4 , further comprising a mutation at one or more additional amino acids selected from the group consisting of: A485, S345, T604, Y497, I630, E645, E578, R465, V401, N424, P569. E617. V640, S651, L396, E459, L456, E658, V437, L478, Y496, Y409 and A490 within the sequence of SEQ ID NO: 2.
8. The isolated recombinant JDF-3 DNA polymerase of claim 7 , wherein said mutation at S345 is serine (S) to proline (P), said mutation at A485 is alanine (A) to threonine (T), cysteine (C), serine (S), leucine (L), isoleucine (I), phenylalanine (F) or valine (V), said mutation at Y497 is tyrosine (Y) to cysteine (C), said mutation at I630 is isoleucine (I) to valine (V), said mutation at E645 is glutamic acid (E) to lysine (L), said mutation at E578 is glutamic acid (E) to lysine (L), said mutation at R465 is arginine (R) to methionine (M), said mutation at L396 is leucine (L) to glutamine (Q) or to proline (P), said mutation at S651 is serine (S) to asparagine (B), said mutation at L456 is leucine (L) to histidine (H), said mutation at Y496 is tyrosine (Y) to asparagine (B) or leucine (L), said mutation at Y409 is tyrosine (Y) to valine (V), said mutation at A490 is alanine (A) to tyrosine (Y).
9. The isolated recombinant JDF-3 DNA polymerase of claim 3 or 4 , wherein said JDF-3 DNA polymerase has reduced discrimination against a non-conventional nucleotide selected from the group consisting of: dideoxynucleotides, ribonucleotides and conjugated nucleotides.
10. The isolated recombinant JDF-3 DNA polymerase of claim 9 , wherein said conjugated nucleotide is selected from the group consisting of radiolabeled nucleotides, fluorescently labeled nucleotides, biotin labeled nucleotides, chemiluminescently labeled nucleotides and quantum dot labeled nucleotides.
11. An isolated JDF-3 DNA polymerase comprising a sequence of SEQ ID NO: 2 and further comprising the following mutations: D141T or D141A, E143A, L408H or L408F, P410L, and A485T within said SEQ ID NO: 2.
12. An isolated JDF-3 DNA polymerase comprising a sequence of SEQ ID NO: 2 and further comprising the following mutations: D141T or D141A and E143A within said SEQ ID NO: 2.
13. An isolated JDF-3 DNA polymerase comprising a sequence of SEQ ID NO: 2 and further comprising the following mutations: D141T or D141A and E143A, and further comprising one or more mutations selected from the group consisting of: L408H or L408F, P410L, and S345P within said SEQ ID NO: 2.
14. An isolated JDF-3 DNA polymerase comprising a sequence of SEQ ID NO: 2 and further comprising mutations at: D141, E143, P410, and A485 within said SEQ ID NO: 2.
15. An isolated JDF-3 DNA polymerase comprising a sequence of SEQ ID NO: 2 and further comprising the following mutations of: D141T or D141A, E143A, P410L, and A485T within said SEQ ID NO: 2.
16. A kit comprising an isolated recombinant polypeptide of claim 2 , and packaging material thereof.
17. A kit comprising an isolated recombinant DNA polymerase of claim 3 or 4 , and packaging material thereof.
18. A kit comprising an isolated recombinant DNA polymerase of claim 5 , and packaging material thereof.
19. A kit comprising an isolated recombinant DNA polymerase of claim 6 , and packaging material thereof.
20. A kit comprising an isolated recombinant DNA polymerase of claim 7 , and packaging material thereof.
21. A kit comprising an isolated recombinant DNA polymerase of claim 8 , and packaging material thereof.
22. A method of making a purified thermostable DNA polymerase of claim 1 , comprising a) transfecting a host cell with the nucleic acid sequence presented in SEQ ID NO: 1, and b) culturing said host cell under conditions which permit production of said DNA polymerase.
23. The method of claim 22 , wherein said host cell is E. Coli or Thermococcus.
24. A method of making a purified thermostable DNA polymerase of claim 3 or 4 , comprising a) transfecting a host cell with a nucleic acid sequence encoding said polymerase and b) culturing said host cell under conditions which permit production of said DNA polymerase.
25. The method of claim 24 , wherein said host cell is E. Coli or Thermococcus.